NEW YORK, March 21, 2023 /PRNewswire/ — The life science software market size is forecast to grow by USD 3,967.58 million between 2022 and 2027. However, the growth momentum will be accelerating at a CAGR of 8.1% during the forecast period. The market is segmented by end-user (pharmaceutical, biotechnology, and others), deployment (cloud-based and on-premise), and geography (North America, Europe, APAC, South America, and Middle East and Africa).
The market will witness maximum growth in the pharmaceutical segment during the forecast period. Pharmaceutical companies are the major end-users in the market. They adopt life sciences software to enhance existing ERP, improve the capabilities of logistic partners, and collaborate with trading partners such as contract packagers. Life sciences software solutions also help pharmaceutical companies throughout the product lifecycle. They lower the time-to-market, speed up research and drug discovery, and streamline commercial operations. All these factors are driving the growth of the segment. For more insights on the historic data (2017 to 2021) and forecast market size (2023 to 2027) – Request a report sample
Company Profiles
The global life science software market is fragmented due to the presence of several global and regional players. Large vendors are entering partnerships and working in collaboration with each other to improve their market presence. They are also acquiring small businesses to expand their customer base and improve market shares. These factors will increase the competition in the market during the forecast period.
The life science software market report includes information on the key products and recent developments of leading vendors, including:
- Cegedim SA. – The company offers life science software such as ActivCloud services, ActivInfinite, iGestion, MyDigitalsales, Hospitalis, and Arkevia.
- Dassault Systemes SE – The company offers life science software such as 3DEXCITE, 3DVIA, BIOVIA, CATIA, and 3DEXPERIENCE.
- Deloitte Touche Tohmatsu Ltd. – The company offers life science software called ConvergeHEALTH software.
- DXC Technology Co. – The company offers life science software through life science analytics, security, cloud, IT outsourcing, and ROI-focused applications.
Regional Analysis
By region, the global life science software market is segmented into North America, Europe, APAC, South America, and Middle East and Africa. North America will account for 49% of market growth during the forecast period. The region is home to some of the major vendors such as SAS Institute Inc., Oracle Corp., and Veeva Systems Inc. In addition, enterprises in the region are early adopters of advanced technologies, such as machine learning, predictive analytics, and quantum and cognitive computing, across business processes. This has led to an increase in the adoption of automation solutions across all business verticals, including the life sciences industry. All these factors are driving the growth of the life science software market in North America.
Market Landscape
The market is driven by factors such as the growing focus on storing patient information, the increasing need for improving operational efficiency and increasing technological innovations. However, frequent changes in mandates will challenge the growth of the market.
Competitive Analysis
The competitive scenario categorizes companies based on various performance indicators. Some of the factors considered include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, and growth in market share among others. Request a Sample
Market Segmentation
- By end-user, the market is segmented into pharmaceutical, biotechnology, and others.
- By deployment, the market is segmented into cloud-based and on-premise.
- By geography, the market is segmented into North America, Europe, APAC, South America, and Middle East and Africa.
Why Buy?
- Add credibility to strategy
- Analyzes competitor’s offerings
- Get a holistic view of the market
Grow your profit margin with Technavio – Buy the Report!
What are the key data covered in this life science software market report?
- CAGR of the market during the forecast period.
- Detailed information on factors that will drive the growth of the market between 2023 and 2027
- Precise estimation of the size of the life science software market and its contribution to the parent market.
- Accurate predictions about upcoming trends and changes in consumer behavior.
- Growth of the market across North America, Europe, APAC, South America, and Middle East and Africa.
- A thorough analysis of the market’s competitive landscape and detailed information about vendors.
- Comprehensive analysis of factors that will challenge the growth of life science software market vendors.
Related Reports:
- The laboratory information management system (LIMS) market is estimated to grow at a CAGR of 9.08% between 2022 and 2027. The size of the market is forecast to increase by USD 907.08 million. The market is segmented by deployment (on-premise and cloud-based), component (software and services), and geography (North America, Europe, Asia, and Rest of World (ROW)).
- The oncology information systems (OIS) market size is expected to increase by USD 1.27 billion from 2021 to 2026, and the market’s growth momentum will accelerate at a CAGR of 7.38%. The market is segmented by product (software and services) and geography (North America, APAC, Europe, South America, and MEA).
Technavio’s library includes over 17,000+ reports, covering more than 2,000 emerging
technologies. Subscribe to our “Basic Plan” at just USD 5,000 and get lifetime access to
Technavio Insights
| Life Science Software Market Scope | |
| Report Coverage | Details |
| Base year | 2022 |
| Historic period | 2017-2021 |
| Forecast period | 2023-2027 |
| Growth momentum & CAGR | Accelerate at a CAGR of 8.1% |
| Market growth 2023-2027 | USD 3967.58 million |
| Market structure | Fragmented |
| YoY growth 2022-2023 (%) | 6.86 |
| Regional analysis | North America, Europe, APAC, South America, and Middle East and Africa |
| Performing market contribution | North America at 49% |
| Key countries | US, Japan, Germany, France, and UK |
| Competitive landscape | Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks |
| Key companies profiled | ArisGlobal LLC, Cegedim SA., Dassault Systemes SE, Deloitte Touche Tohmatsu Ltd., DXC Technology Co., EPAM Systems Inc., Fujitsu Ltd., HCL Technologies Ltd., International Business Machines Corp., Model N Inc., Oracle Corp., Persistent Systems Ltd., PTC Therapeutics Inc., SAS Institute Inc., Signiant Inc., Thermo Fisher Scientific Inc., TIBCO Software Inc., Veeva Systems Inc., SAP SE, and Sryas |
| Market dynamics | Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the forecast period. |
| Customization purview | If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
1 Executive Summary
- 1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Deployment
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
- 2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics
3 Market Sizing
- 3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition
- 3.2 Market segment analysis
- Exhibit 13: Market segments
- 3.3 Market size 2022
- 3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
- 4.1 Global life science software market 2017 – 2021
- Exhibit 18: Historic Market Size – Data Table on Global life science software market 2017 – 2021 ($ million)
- 4.2 End User Segment Analysis 2017 – 2021
- Exhibit 19: Historic Market Size – End User Segment 2017 – 2021 ($ million)
- 4.3 Deployment Segment Analysis 2017 – 2021
- Exhibit 20: Historic Market Size – Deployment Segment 2017 – 2021 ($ million)
- 4.4 Geography Segment Analysis 2017 – 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
- 4.5 Country Segment Analysis 2017 – 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
- 5.1 Five forces summary
- Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
- 5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
- 5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
- 5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
- 5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
- 5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
- 5.7 Market condition
- Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by End-user
- 6.1 Market segments
- Exhibit 30: Chart on End-user – Market share 2022-2027 (%)
- Exhibit 31: Data Table on End-user – Market share 2022-2027 (%)
- 6.2 Comparison by End-user
- Exhibit 32: Chart on Comparison by End-user
- Exhibit 33: Data Table on Comparison by End-user
- 6.3 Pharmaceutical – Market size and forecast 2022-2027
- Exhibit 34: Chart on Pharmaceutical – Market size and forecast 2022-2027 ($ million)
- Exhibit 35: Data Table on Pharmaceutical – Market size and forecast 2022-2027 ($ million)
- Exhibit 36: Chart on Pharmaceutical – Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Pharmaceutical – Year-over-year growth 2022-2027 (%)
- 6.4 Biotechnology – Market size and forecast 2022-2027
- Exhibit 38: Chart on Biotechnology – Market size and forecast 2022-2027 ($ million)
- Exhibit 39: Data Table on Biotechnology – Market size and forecast 2022-2027 ($ million)
- Exhibit 40: Chart on Biotechnology – Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on Biotechnology – Year-over-year growth 2022-2027 (%)
- 6.5 Others – Market size and forecast 2022-2027
- Exhibit 42: Chart on Others – Market size and forecast 2022-2027 ($ million)
- Exhibit 43: Data Table on Others – Market size and forecast 2022-2027 ($ million)
- Exhibit 44: Chart on Others – Year-over-year growth 2022-2027 (%)
- Exhibit 45: Data Table on Others – Year-over-year growth 2022-2027 (%)
- 6.6 Market opportunity by End-user
- Exhibit 46: Market opportunity by End-user ($ million)
- Exhibit 47: Data Table on Market opportunity by End-user ($ million)
7 Market Segmentation by Deployment
- 7.1 Market segments
- Exhibit 48: Chart on Deployment – Market share 2022-2027 (%)
- Exhibit 49: Data Table on Deployment – Market share 2022-2027 (%)
- 7.2 Comparison by Deployment
- Exhibit 50: Chart on Comparison by Deployment
- Exhibit 51: Data Table on Comparison by Deployment
- 7.3 Cloud-based – Market size and forecast 2022-2027
- Exhibit 52: Chart on Cloud-based – Market size and forecast 2022-2027 ($ million)
- Exhibit 53: Data Table on Cloud-based – Market size and forecast 2022-2027 ($ million)
- Exhibit 54: Chart on Cloud-based – Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Cloud-based – Year-over-year growth 2022-2027 (%)
- 7.4 On-premise – Market size and forecast 2022-2027
- Exhibit 56: Chart on On-premise – Market size and forecast 2022-2027 ($ million)
- Exhibit 57: Data Table on On-premise – Market size and forecast 2022-2027 ($ million)
- Exhibit 58: Chart on On-premise – Year-over-year growth 2022-2027 (%)
- Exhibit 59: Data Table on On-premise – Year-over-year growth 2022-2027 (%)
- 7.5 Market opportunity by Deployment
- Exhibit 60: Market opportunity by Deployment ($ million)
- Exhibit 61: Data Table on Market opportunity by Deployment ($ million)
8 Customer Landscape
- 8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
- 9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2022-2027 (%)
- Exhibit 64: Data Table on Market share by geography 2022-2027 (%)
- 9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison
- 9.3 North America – Market size and forecast 2022-2027
- Exhibit 67: Chart on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 68: Data Table on North America – Market size and forecast 2022-2027 ($ million)
- Exhibit 69: Chart on North America – Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on North America – Year-over-year growth 2022-2027 (%)
- 9.4 Europe – Market size and forecast 2022-2027
- Exhibit 71: Chart on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 72: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
- Exhibit 73: Chart on Europe – Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Europe – Year-over-year growth 2022-2027 (%)
- 9.5 APAC – Market size and forecast 2022-2027
- Exhibit 75: Chart on APAC – Market size and forecast 2022-2027 ($ million)
- Exhibit 76: Data Table on APAC – Market size and forecast 2022-2027 ($ million)
- Exhibit 77: Chart on APAC – Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on APAC – Year-over-year growth 2022-2027 (%)
- 9.6 South America – Market size and forecast 2022-2027
- Exhibit 79: Chart on South America – Market size and forecast 2022-2027 ($ million)
- Exhibit 80: Data Table on South America – Market size and forecast 2022-2027 ($ million)
- Exhibit 81: Chart on South America – Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on South America – Year-over-year growth 2022-2027 (%)
- 9.7 Middle East and Africa – Market size and forecast 2022-2027
- Exhibit 83: Chart on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
- Exhibit 84: Data Table on Middle East and Africa – Market size and forecast 2022-2027 ($ million)
- Exhibit 85: Chart on Middle East and Africa – Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Middle East and Africa – Year-over-year growth 2022-2027 (%)
- 9.8 US – Market size and forecast 2022-2027
- Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ million)
- Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
- 9.9 Germany – Market size and forecast 2022-2027
- Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
- Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
- 9.10 France – Market size and forecast 2022-2027
- Exhibit 95: Chart on France – Market size and forecast 2022-2027 ($ million)
- Exhibit 96: Data Table on France – Market size and forecast 2022-2027 ($ million)
- Exhibit 97: Chart on France – Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on France – Year-over-year growth 2022-2027 (%)
- 9.11 UK – Market size and forecast 2022-2027
- Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ million)
- Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ million)
- Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
- Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
- 9.12 Japan – Market size and forecast 2022-2027
- Exhibit 103: Chart on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 104: Data Table on Japan – Market size and forecast 2022-2027 ($ million)
- Exhibit 105: Chart on Japan – Year-over-year growth 2022-2027 (%)
- Exhibit 106: Data Table on Japan – Year-over-year growth 2022-2027 (%)
- 9.13 Market opportunity by geography
- Exhibit 107: Market opportunity by geography ($ million)
- Exhibit 108: Data Tables on Market opportunity by geography ($ million)
10 Drivers, Challenges, and Trends
- 10.1 Market drivers
- 10.2 Market challenges
- 10.3 Impact of drivers and challenges
- Exhibit 109: Impact of drivers and challenges in 2022 and 2027
- 10.4 Market trends
11 Vendor Landscape
- 11.1 Overview
- 11.2 Vendor landscape
- Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
- 11.3 Landscape disruption
- Exhibit 111: Overview on factors of disruption
- 11.4 Industry risks
- Exhibit 112: Impact of key risks on business
12 Vendor Analysis
- 12.1 Vendors covered
- Exhibit 113: Vendors covered
- 12.2 Market positioning of vendors
- Exhibit 114: Matrix on vendor position and classification
- 12.3 ArisGlobal LLC
- Exhibit 115: ArisGlobal LLC – Overview
- Exhibit 116: ArisGlobal LLC – Product / Service
- Exhibit 117: ArisGlobal LLC – Key offerings
- 12.4 Cegedim SA.
- Exhibit 118: Cegedim SA. – Overview
- Exhibit 119: Cegedim SA. – Business segments
- Exhibit 120: Cegedim SA. – Key offerings
- Exhibit 121: Cegedim SA. – Segment focus
- 12.5 Dassault Systemes SE
- Exhibit 122: Dassault Systemes SE – Overview
- Exhibit 123: Dassault Systemes SE – Product / Service
- Exhibit 124: Dassault Systemes SE – Key news
- Exhibit 125: Dassault Systemes SE – Key offerings
- 12.6 Deloitte Touche Tohmatsu Ltd.
- Exhibit 126: Deloitte Touche Tohmatsu Ltd. – Overview
- Exhibit 127: Deloitte Touche Tohmatsu Ltd. – Business segments
- Exhibit 128: Deloitte Touche Tohmatsu Ltd. – Key offerings
- Exhibit 129: Deloitte Touche Tohmatsu Ltd. – Segment focus
- 12.7 DXC Technology Co.
- Exhibit 130: DXC Technology Co. – Overview
- Exhibit 131: DXC Technology Co. – Business segments
- Exhibit 132: DXC Technology Co. – Key news
- Exhibit 133: DXC Technology Co. – Key offerings
- Exhibit 134: DXC Technology Co. – Segment focus
- 12.8 EPAM Systems Inc.
- Exhibit 135: EPAM Systems Inc. – Overview
- Exhibit 136: EPAM Systems Inc. – Business segments
- Exhibit 137: EPAM Systems Inc. – Key offerings
- Exhibit 138: EPAM Systems Inc. – Segment focus
- 12.9 International Business Machines Corp.
- Exhibit 139: International Business Machines Corp. – Overview
- Exhibit 140: International Business Machines Corp. – Business segments
- Exhibit 141: International Business Machines Corp. – Key offerings
- Exhibit 142: International Business Machines Corp. – Segment focus
- 12.10 Model N Inc.
- Exhibit 143: Model N Inc. – Overview
- Exhibit 144: Model N Inc. – Business segments
- Exhibit 145: Model N Inc. – Key offerings
- Exhibit 146: Model N Inc. – Segment focus
- 12.11 Oracle Corp.
- Exhibit 147: Oracle Corp. – Overview
- Exhibit 148: Oracle Corp. – Business segments
- Exhibit 149: Oracle Corp. – Key news
- Exhibit 150: Oracle Corp. – Key offerings
- Exhibit 151: Oracle Corp. – Segment focus
- 12.12 PTC Therapeutics Inc.
- Exhibit 152: PTC Therapeutics Inc. – Overview
- Exhibit 153: PTC Therapeutics Inc. – Business segments
- Exhibit 154: PTC Therapeutics Inc. – Key offerings
- Exhibit 155: PTC Therapeutics Inc. – Segment focus
- 12.13 SAP SE
- Exhibit 156: SAP SE – Overview
- Exhibit 157: SAP SE – Business segments
- Exhibit 158: SAP SE – Key news
- Exhibit 159: SAP SE – Key offerings
- Exhibit 160: SAP SE – Segment focus
- 12.14 SAS Institute Inc.
- Exhibit 161: SAS Institute Inc. – Overview
- Exhibit 162: SAS Institute Inc. – Product / Service
- Exhibit 163: SAS Institute Inc. – Key news
- Exhibit 164: SAS Institute Inc. – Key offerings
- 12.15 Sryas
- Exhibit 165: Sryas – Overview
- Exhibit 166: Sryas – Product / Service
- Exhibit 167: Sryas – Key offerings
- 12.16 Thermo Fisher Scientific Inc.
- Exhibit 168: Thermo Fisher Scientific Inc. – Overview
- Exhibit 169: Thermo Fisher Scientific Inc. – Business segments
- Exhibit 170: Thermo Fisher Scientific Inc. – Key news
- Exhibit 171: Thermo Fisher Scientific Inc. – Key offerings
- Exhibit 172: Thermo Fisher Scientific Inc. – Segment focus
- 12.17 Veeva Systems Inc.
- Exhibit 173: Veeva Systems Inc. – Overview
- Exhibit 174: Veeva Systems Inc. – Business segments
- Exhibit 175: Veeva Systems Inc. – Key offerings
- Exhibit 176: Veeva Systems Inc. – Segment focus
13 Appendix
- 13.1 Scope of the report
- 13.2 Inclusions and exclusions checklist
- Exhibit 177: Inclusions checklist
- Exhibit 178: Exclusions checklist
- 13.3 Currency conversion rates for US$
- Exhibit 179: Currency conversion rates for US$
- 13.4 Research methodology
- Exhibit 180: Research methodology
- Exhibit 181: Validation techniques employed for market sizing
- Exhibit 182: Information sources
- 13.5 List of abbreviations
- Exhibit 183: List of abbreviations
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/
View original content to download multimedia:https://www.prnewswire.com/news-releases/life-science-software-market-size-to-increase-by-usd-3-967-58-million-between-2022-and-2027-arisglobal-llc-cegedim-sa-among-others-identified-as-key-vendors—technavio-301777754.html
SOURCE Technavio
